Reversible and adaptive resistance to BRAF (V600E) inhibition in melanoma

C Sun, L Wang, S Huang, GJJE Heynen, A Prahallad… - Nature, 2014 - nature.com
Abstract Treatment of BRAF (V600E) mutant melanoma by small molecule drugs that target
the BRAF or MEK kinases can be effective, but resistance develops invariably,. In contrast …
被引用次数：914 相关文章

Reversible and adaptive resistance to BRAF (V600E) inhibition in melanoma

C Sun, L Wang, S Huang, GJJE Heynen, A Prahallad… - Nature, 2014 - ideas.repec.org
Patients with melanomas carrying an activating BRAF mutation respond to treatment with
BRAF inhibitors although resistance to the inhibitor usually emerges; this resistance is …

Reversible and adaptive resistance to BRAF (V600E) inhibition in melanoma.

C Sun, L Wang, S Huang, G Heynen, A Prahallad… - NATURE, 2014 - iris.unito.it
Treatment of BRAF (V600E) mutant melanoma by small molecule drugs that target the BRAF
or MEK kinases can be effective, but resistance develops invariably. In contrast, colon …

Reversible and adaptive resistance to BRAF (V600E) inhibition in melanoma

C Sun, L Wang, S Huang, GJJE Heynen, A Prahallad… - Nature, 2014 - research.rug.nl
Abstract Treatment of BRAF (V600E) mutant melanoma by small molecule drugs that target
the BRAF or MEK kinases can be effective, but resistance develops invariably. In contrast …

Reversible and adaptive resistance to BRAF (V600E) inhibition in melanoma

C Sun, L Wang, S Huang, GJJE Heynen… - …, 2014 - pubmed.ncbi.nlm.nih.gov
Treatment of BRAF (V600E) mutant melanoma by small molecule drugs that target the BRAF
or MEK kinases can be effective, but resistance develops invariably. In contrast, colon …

[引用][C] Reversible and adaptive resistance to BRAF (V600E) inhibition in melanoma

C Sun, L Wang, S Huang, GJJE Heynen, A Prahallad… - Nature, 2014 - cir.nii.ac.jp

Reversible and adaptive resistance to BRAF (V600E) inhibition in melanoma.

C Sun, L Wang, S Huang, GJ Heynen, A Prahallad… - Nature, 2014 - europepmc.org
Treatment of BRAF (V600E) mutant melanoma by small molecule drugs that target the BRAF
or MEK kinases can be effective, but resistance develops invariably. In contrast, colon …

Reversible and adaptive resistance to BRAF (V600E) inhibition in melanoma

C Sun, L Wang, S Huang, GJJE Heynen, A Prahallad… - Nature, 2014 - go.gale.com
Patients with melanomas carrying an activating BRAF mutation respond to treatment with
BRAF inhibitors although resistance to the inhibitor usually emerges; this resistance is …

Reversible and adaptive resistance to BRAF (V600E) inhibition in melanoma

C Sun, L Wang, S Huang, GJJE Heynen… - Nature, 2014 - econpapers.repec.org
Patients with melanomas carrying an activating BRAF mutation respond to treatment with
BRAF inhibitors although resistance to the inhibitor usually emerges; this resistance is …
[PDF] academia.edu

[PDF][PDF] Reversible and adaptive resistance to BRAF (V600E) inhibition in melanoma.

C Sun, L Wang, S Huang, GJJE Heynen, A Prahallad… - academia.edu
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma. Chong Sun1*,
Liqin Wang1*, Sidong Huang1, 2*, Guus JJ Page 1 Reversible and adaptive resistance to …